The median survival for SMARCA4-deficient gastric carcinoma is less than one year from diagnosis, whereas the median survival for SMARCA4-deficient thoracic sarcomas is only six months from diagnosis (20, 21). Here, SMARCA4 is linked to gastric carcinoma.